CHANDAN — Chandan Healthcare Income Statement
0.000.00%
- IN₹7.24bn
- IN₹7.78bn
- IN₹2.30bn
Annual income statement for Chandan Healthcare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | C2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 1,196 | 1,369 | 1,766 | 2,301 |
| Cost of Revenue | ||||
| Gross Profit | 558 | 704 | 936 | 1,193 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 1,193 | 1,296 | 1,534 | 1,942 |
| Operating Profit | 2.94 | 72.9 | 231 | 360 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -10.6 | 50.1 | 215 | 321 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -10.9 | 35.9 | 164 | 235 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | -11.1 | 33.7 | 163 | 222 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -11.1 | 33.7 | 163 | 222 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.454 | 1.38 | 6.66 | 10.8 |